Effect Of Erand Taila Yonipichu In Chronic Pelvic Inflammatory Disease.

RANDOMIZED CONTROLLED CLINICAL TRIAL OF ERAND TAILA YONIPICHU IN THE MANAGEMENT OF PARIPLUTA YONIVYAPAD WITH SPECIAL REFERENCE TO CHRONIC PELVIC INFLAMMATORY DISEASE. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091825

Enrollment

Registered

2025-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Only Married women in between Age group of 21-50 yrs. 2. Patient having specific symptoms of chronic pelvic inflammatory disease like chronic pain in abdomen, previous history of acute pelvic inflammatory disease malaise associated with lower abdominal pain and tenderness.

Exclusion criteria

Exclusion criteria: 1.Patients having Malignant or Benign tumor, Polyp, Fibroid, Endometriosis, Tubo-Ovarian Mass, Adenomyosis etc. 2. Pregnant women 3.Unmarried women 4.Known case of Diabetes mellitus,HTN ,Asthma 5. Patients with pelvic inflammatory disease when seen associated with prolapsed uterus. 6 Known case of HIV ,VDRL.

Design outcomes

Primary

Measure	Time frame
Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,RujaTimepoint: 7 Days	—

Secondary

Measure	Time frame
Significant Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishool,RujaTimepoint: 2 Month	—

Countries

India

Contacts

Public ContactDrSachin Jagannath Patil

LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli

Sachinpatil5190@gmail.com9422407301

Outcome results